160 related articles for article (PubMed ID: 23452101)
1. A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
Kamata M; Sugaya M; Miyagaki T; Sonoda K; Ichimura Y; Mitsui H; Sato S; Kamikubo Y; Kurokawa M
Int J Dermatol; 2014 Jan; 53(1):e24-6. PubMed ID: 23452101
[No Abstract] [Full Text] [Related]
2. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
[TBL] [Abstract][Full Text] [Related]
3. CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.
Kakinoki Y; Hashiguchi J; Ishio T; Chiba K; Niino D; Ohshima K
Int J Hematol; 2015 Dec; 102(6):702-8. PubMed ID: 26251099
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Maruyama D
Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
[No Abstract] [Full Text] [Related]
5. [Malignant lymphoma and adult T-cell leukemia-lymphoma].
Kato K
Rinsho Ketsueki; 2014 Feb; 55(2):191-200. PubMed ID: 24598187
[No Abstract] [Full Text] [Related]
6. Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.
Park Y; Choi YJ; Park SJ; Lee SR; Sung HJ; Park KH; Kim SJ; Choi CW; Jung KY; Kim BS
Acta Haematol; 2011; 126(2):79-86. PubMed ID: 21540579
[TBL] [Abstract][Full Text] [Related]
7. [Treatment strategy of gray zone lymphomas].
Maruyama D
Rinsho Ketsueki; 2014 Oct; 55(10):1912-9. PubMed ID: 25297755
[No Abstract] [Full Text] [Related]
8. Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
Gutierrez A; Rodriguez J
Ann Oncol; 2008 Aug; 19(8):1512. PubMed ID: 18662957
[No Abstract] [Full Text] [Related]
9. Successful allogeneic stem cell transplantation for Lennert lymphoma.
Uni M; Yoshimi A; Nakamura F; Takazawa Y; Fukayama M; Kurokawa M
Ann Hematol; 2013 Jun; 92(6):859-60. PubMed ID: 23224245
[No Abstract] [Full Text] [Related]
10. Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by cryoprobe.
Pajares V; Torrego A; Granell M; Szafranska J; Mozos A; Puzo C
Arch Bronconeumol; 2013 May; 49(5):210-2. PubMed ID: 22981515
[TBL] [Abstract][Full Text] [Related]
11. [Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma].
Uzuka Y; Saitou Y; Saitou K; Suzuki S; Yamaguchi M
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1085-90. PubMed ID: 17637545
[TBL] [Abstract][Full Text] [Related]
12. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
13. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
14. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
15. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
[TBL] [Abstract][Full Text] [Related]
16. Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
Czuczman MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-46-52. PubMed ID: 23570100
[No Abstract] [Full Text] [Related]
17. [Rituximab, a chimeric mouse-human anti-CD20 monoclonal antibody].
Tobinai K
Nihon Rinsho; 2002 Mar; 60(3):468-72. PubMed ID: 11904960
[TBL] [Abstract][Full Text] [Related]
18. Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.
Suzuki Y; Yoshida T; Wang G; Togano T; Miyamoto S; Miyazaki K; Iwabuchi K; Nakayama M; Horie R; Niitsu N; Sato Y; Nakamura N
Ann Hematol; 2012 Jul; 91(7):997-1005. PubMed ID: 22249209
[TBL] [Abstract][Full Text] [Related]
19. Pegfilgrastim-induced pain in patients with lymphoma.
Mullen EC
Oncol Nurs Forum; 2014 Mar; 41(2):212-4. PubMed ID: 24578081
[No Abstract] [Full Text] [Related]
20. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.
Decker M; Rothermundt C; Holländer G; Tichelli A; Rochlitz C
Lancet Oncol; 2006 Aug; 7(8):693-4. PubMed ID: 16887487
[No Abstract] [Full Text] [Related]
[Next] [New Search]
